Eudralex Volume 3 Draft : Revision of CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products

Titel:
Eudralex Volume 3 Draft : Revision of CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products
Herkunft/Verlag:

European Commission Enterprise and Industry DG, BREY 13/ 092, B - 1049 Brussels (Belgium), http://ec.europa.eu/enterprise/

Dokumentenart:
Draft Guideline
Inhalt:
Revision des Positionspapiers von 2004

Zurück

GMP Seminare nach Thema